CIG
BMY icon

Cairn Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Cairn Investment Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,215
Closed -$206K – 70
2019
Q4 		$206K Buy
+3,215
New +$184K 0.2% 86

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cairn Investment Group's BMY Position: Q1 2020 in Review

Cairn Investment Group sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 3,215 shares — an estimated $206K sold.

Cairn Investment Group first reported a position in BMY in Q4 2019 and held it in 1 quarter. The position peaked at $206K in Q4 2019. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Cairn Investment Group reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • Cairn Investment Group sold 3,215 Bristol-Myers Squibb shares in Q1 2020, an estimated $206K.
  • Cairn Investment Group first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 1 quarter.
  • Cairn Investment Group's Bristol-Myers Squibb position peaked at $206K in Q4 2019.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Cairn Investment Group's 13F filing for Q1 2020, filed 24 Apr 2020.